OOIR: Observatory of International Research

Papers

(The H4-Index of Cephalalgia is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Efficacy of different cannabinoid compounds on migraine-like responses in female rats	104
Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controll	98
Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care	73
Genetic characterization of the endocannabinoid system and psychiatric features in patients with migraine and medication overuse headache	73
Visual snow vs. migraine aura: Debate summary and novel insights into the syndrome	66
A reply, drug-induced reversible cerebral vasoconstriction syndrome: Lessons from the real world	62
Harassment in the headache field: a global web-based cross-sectional survey	56
International Classification of Headache Disorders-4 – Work in Progress 1	41
Evidence-based guidelines for the pharmacological treatment of migraine	40
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials	40
Corticosteroid-dependent increased expression of CGRP and its receptor subunits within the rodent trigeminal ganglion does not prompt cephalic allodynia	39
Impact of psychiatric comorbidity, resilience and executive function on childhood and adolescent headaches: A narrative review	38
Rethinking migraine with aura: Why cortical spreading depolarization (depression), not aura, causes headaches	38
Systemic lupus erythematosus mimicking retinal migraine: a case report	38
Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex	37
Population-based prevalence of cranial autonomic symptoms in migraine and proposed diagnostic appendix criteria	37
Depression screening in migraine - A double-edged sword	35
Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study	34
Childhood and adolescent headache: A problem not to be ignored in the era of new therapies	34
Comment on “What predicts citation counts and translational impact in headache research? A machine learning analysis”	33
Painful nervus intermedius neuropathy attributed to Bell's palsy: The need for independent diagnostic criteria	33
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury	32
History of maternal migraine and its association with preeclampsia: A case–control study in a low-resource setting in Sudan, Africa	32
Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization	32
IHC 2025 late-breaking abstracts	31

The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system	31
Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment	30
Pain sensitivities predict prophylactic treatment outcomes of flunarizine in chronic migraine patients: A prospective study	30
Effect of Altmetric score on manuscript citations: A randomized-controlled trial	29
An altered reward system characterizes chronic migraine with medication overuse headache	29
COVID-19 vaccination-triggered cluster headache episodes with frequent attacks	29